The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.

To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed to not trigger those dangers.